SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:gup.ub.gu.se/277286"
 

Search: id:"swepub:oai:gup.ub.gu.se/277286" > Fixed But Not Autoa...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Fixed But Not Autoadjusting Positive Airway Pressure Attenuates the Time-dependent Decline in Glomerular Filtration Rate in Patients With OSA

Marrone, O. (author)
Cibella, F. (author)
Pepin, J. L. (author)
show more...
Grote, Ludger, 1964 (author)
Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine
Verbraecken, J. (author)
Saaresranta, T. (author)
Kvamme, J. A. (author)
Basoglu, O. K. (author)
Lombardi, C. (author)
McNicholas, W. T. (author)
Hedner, Jan A, 1953 (author)
Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine
Bonsignore, M. R. (author)
Esada Network, Esada Network (author)
show less...
 (creator_code:org_t)
Elsevier BV, 2018
2018
English.
In: Chest. - : Elsevier BV. - 0012-3692. ; 154:2, s. 326-334
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • BACKGROUND: The impact of treating OSA on renal function decline is controversial. Previous studies usually included small samples and did not consider specific effects of different CPAP modalities. The aim of this study was to evaluate the respective influence of fixed and autoadjusting CPAP modes on estimated glomerular filtration rate (eGFR) in a large sample of patients derived from the prospective European Sleep Apnea Database cohort. METHODS: In patients of the European Sleep Apnea Database, eGFR prior to and after follow-up was calculated by using the Chronic Kidney Disease-Epidemiology Collaboration equation. Three study groups were investigated: untreated patients (n = 144), patients receiving fixed CPAP (fCPAP) (n = 1,178), and patients on autoadjusting CPAP (APAP) (n = 485). RESULTS: In the whole sample, eGFR decreased over time. The rate of eGFR decline was significantly higher in the subgroup with eGFR above median (91.42 mL/min/1.73 m(2)) at baseline (P < .0001 for effect of baseline eGFR). This decline was attenuated or absent (P < .0001 for effect of treatment) in the subgroup of patients with OSA treated by using fCPAP. A follow-up duration exceeding the median (541 days) was associated with eGFR decline in the untreated and APAP groups but not in the fCPAP group (P < .0001 by two-way ANOVA for interaction between treatment and follow-up length). In multiple regression analysis, eGFR decline was accentuated by advanced age, female sex, cardiac failure, higher baseline eGFR, and longer follow-up duration, whereas there was a protective effect of fCPAP. CONCLUSIONS: fCPAP but not APAP may prevent eGFR decline in OSA.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Urology and Nephrology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Oto-rhino-laryngologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Otorhinolaryngology (hsv//eng)

Keyword

automatic CPAP
fixed CPAP
glomerular filtration rate
OSA
therapy
obstructive sleep-apnea
chronic kidney-disease
renal-disease
large
cohort
association
metaanalysis
progression
risk
hypertension
gender

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • Chest (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view